Researchers use radioactive listeria to target pancreatic cancer

04/26/2013 | New Scientist

Researchers have found that modified listeria bacteria can target primary and metastatic tumors in pancreatic cancer without harming healthy tissue. To improve the bacteria's targeting capability, the researchers used an antibody to attach the radioisotope rhenium-188 to the listeria. Tests on mice showed the radioactive treatment, without harming the livers and kidneys, led to a decrease in the number of metastatic tumors and weights of original tumors, according to the study published in the Proceedings of the National Academy of Sciences. A potential approach for clinical studies would be to remove the original tumor and eliminate the remaining lesions with radioactive listeria, a researcher said.

View Full Article in:

New Scientist

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC